Drug intelligence / Profile preview

SF2000SD

Development stage: Phase 1
Lead developer: Tropical Diseases Research Centre
Modality: Small Molecules
Administration: Oral

Overview

SF2000SD is a spray-dried extract derived from a traditional remedy used by a Zambian traditional healer for treating HIV/AIDS. It underwent a Phase I clinical trial that demonstrated safety and tolerability in healthy male volunteers, but a planned Phase II efficacy trial in HIV-infected individuals could not proceed.

Beyond the preview

Go deeper on SF2000SD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SF2000SD.

Explore the full profile